首页> 外文期刊>The journal of immunology >Atherogenic Lipids Induce High-Density Lipoprotein Uptake and Cholesterol Efflux in Human Macrophages by Up-Regulating Transmembrane Chemokine CXCL16 without Engaging CXCL16-Dependent Cell Adhesion
【24h】

Atherogenic Lipids Induce High-Density Lipoprotein Uptake and Cholesterol Efflux in Human Macrophages by Up-Regulating Transmembrane Chemokine CXCL16 without Engaging CXCL16-Dependent Cell Adhesion

机译:致动脉粥样硬化的脂质通过上调跨膜趋化因子CXCL16而不参与CXCL16依赖的细胞粘附诱导人巨噬细胞高密度脂蛋白的摄取和胆固醇外流。

获取原文
           

摘要

Atherosclerosis is a complex pathologic process in which chemokine-mediated leukocyte accumulation in arterial walls is thought to be an important mechanism of pathogenesis. An interesting exception to this paradigm is the chemokine CXCL16, also known as the scavenger receptor for phosphatidylserine and oxidized low density lipoprotein, which is highly expressed in mouse and human atherosclerotic lesions, yet appears to be atheroprotective. In this study, we address potential mechanisms responsible for this activity. Consistent with its presence in atherosclerotic plaque, we found that atherogenic lipids up-regulated CXCL16 in primary human monocyte-derived macrophages. However, the same lipids down-regulated the CXCL16-targeted protease ADAM10, resulting in preferential expression of CXCL16 as the transmembrane form, not the shed form. Although transmembrane CXCL16 is known to mediate cell-cell adhesion by binding its receptor CXCR6, and atherogenic lipids are known to stimulate macrophage adhesion to coronary artery smooth muscle cells, we found that heterotypic adhesion of these cell types occurred in a CXCL16-independent manner. Instead we found that in macrophages, CXCL16 promoted internalization of both oxidized low density lipoprotein and high density lipoprotein, as well as release of cholesterol. Moreover, CXCL16 deficiency in macrophages interfered with oxidized low density lipoprotein-induced up-regulation of atheroprotective genes: adenosine triphosphate-binding cassette transporter A1 and G1 as well as apolipoprotein E. Thus, our findings support the hypothesis that CXCL16 mediates atheroprotection through its scavenger role in macrophages and not by cell-cell adhesion.
机译:动脉粥样硬化是一个复杂的病理过程,其中趋化因子介导的白细胞在动脉壁的积累被认为是发病的重要机制。该范例的一个有趣的例外是趋化因子CXCL16,也称为磷脂酰丝氨酸和氧化的低密度脂蛋白的清除剂受体,其在小鼠和人的动脉粥样硬化病变中高表达,但似乎具有抗动脉粥样硬化的作用。在这项研究中,我们探讨了造成这一活动的潜在机制。与它在动脉粥样硬化斑块中的存在一致,我们发现致动脉粥样硬化的脂质在原代人单核细胞衍生的巨噬细胞中上调了CXCL16。但是,相同的脂质下调了靶向CXCL16的蛋白酶ADAM10,导致CXCL16优先表达为跨膜形式,而不是脱落形式。尽管已知跨膜CXCL16通过结合其受体CXCR6来介导细胞粘附,并且已知致动脉粥样硬化的脂质刺激巨噬细胞粘附至冠状动脉平滑肌细胞,但我们发现这些细胞类型的异型粘附以CXCL16独立的方式发生。相反,我们发现在巨噬细胞中,CXCL16促进了氧化的低密度脂蛋白和高密度脂蛋白的内在化,以及胆固醇的释放。此外,巨噬细胞中的CXCL16缺乏会干扰氧化的低密度脂蛋白诱导的动脉粥样硬化保护基因的上调:三磷酸腺苷结合盒转运蛋白A1和G1以及载脂蛋白E。因此,我们的发现支持以下假设:CXCL16通过其清除剂介导动脉粥样硬化保护。作用于巨噬细胞而不是通过细胞间粘附。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号